A study of rheumatoid arthritis management with the triple combination of methotrexate + hydroxychloroquine + sulfasalazine and double combination of methotrexate + hydroxychloroquine
نویسندگان
چکیده
Rheumatoid arthritis is chronic multisystem disease, failure rate with monotherapy is high. The present study was designed to compare the efficacy and safety of triple combination of Methotrexate + Hydroxychloroquine + Sulfasalazine and double combination of Methotrexate + Hydroxychloroquine in patients suffering from Rheumatoid Arthritis. The present study was a prospective, randomized, single blind comparative study of 24 weeks duration. 60 patients were included which were assigned two groups, A and B with 30 patients in each group. Group A was given Methotrexate (MTX) 7.5 mg once a week + Hydroxychloroquine (HCQ) 200mg OD + Sulfasalazine (SSZ) 500 mg BD and Group B was given Methotrexate 7.5 mg once a week + Hydroxychloroquine 200 mg OD. The patients were evaluated for clinical efficacy and safety using different clinical and laboratory parameters. There was a significant reduction in various parameters in group A as compared to group B indicating superiority of the triple combination over the double combination. Based on our findings we suggest that the triple combination of MTX, HCQ and SSZ is more efficacious and equally tolerable than the double combination of MTX and SSZ in patients suffering from RA.
منابع مشابه
Use of combination therapy in the routine care of patients with rheumatoid arthritis: physician and patient surveys.
AIMS To describe the utilization of combination therapy in the treatment of rheumatoid arthritis (RA). METHODS Review of published articles and abstracts, and patient/physician questionnaire data. RESULTS Combination therapy was rarely used in the early 1980s and is now (1999) used for about 25% of RA patients in the US. Physician and patient surveys indicate that methotrexate plus hydroxyc...
متن کاملCombination therapy in rheumatoid arthritis: updated systematic review.
In a second update of a systematic review, many new developments in the combined drug treatment of rheumatoid arthritis (RA) are highlighted. In early RA patients, step-down bridge therapy that includes corticosteroids leads to much enhanced efficacy at acceptable or low toxicity. The effects on joint damage may be persistent, but the symptomatic effects are probably dependent on continued cort...
متن کاملCombination DMARD therapy with hydroxychloroquine, sulfasalazine, and methotrexate.
Triple combination therapy with hydroxychloroquine, sulfasalazine, and methotrexate (MTX) has been shown in double-blind, placebo-controlled studies to be significantly superior to MTX alone (Paulus 50% responses of 77% versus 33%). In long-term follow-up studies, this therapy has now been shown to be well-tolerated with continued efficacy in the majority of patients.
متن کاملMethotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying antirheumatic drugs for rheumatoid arthritis: abridged Cochrane systematic review and network meta-analysis.
OBJECTIVE To compare methotrexate based disease modifying antirheumatic drug (DMARD) treatments for rheumatoid arthritis in patients naive to or with an inadequate response to methotrexate. DESIGN Systematic review and Bayesian random effects network meta-analysis of trials assessing methotrexate used alone or in combination with other conventional synthetic DMARDs, biologic drugs, or tofacit...
متن کاملCombination therapy in rheumatoid arthritis.
It has become clear that early suppression of rheumatoid arthritis disease activity is important in preventing progressive joint destruction and functional decline. To achieve this goal, many rheumatologists today advocate a more aggressive approach, using combinations of classic disease-modifying antirheumatic drugs-often including methotrexate-or new drugs. During the last 2 years, the combin...
متن کامل